MeVis Medical Solutions AG

ETR-M3V
Deutsche Börse Xetra NYSE
Healthcare Health Information Services
Global Rank
#29086
Country Rank
#387
Market Cap
52.26 M
Price
28.71
Change (%)
1.59%
Volume
405

ETR-M3V's Next Dividend

Next Estimated Amount
€0.95
Next Estimated Pay Date
04/03/2026
Last Amount
€0.95
Last Pay Date
03/28/2025
Dividend Shot Clock Ex-Date: 03/26/2025
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

MeVis Medical Solutions AG Dividend Chart

*Amounts are shown in the stock exchange currency (EUR) for convenience

MeVis Medical Solutions AG(ETR-M3V) Dividend History

MeVis Medical Solutions AG (ETR-M3V) currently pays an annual dividend of $0.95 per share, offering a dividend yield of 3.77%. The next dividend payout date has not been announced.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2025 €0.95 0%
03/26/2025 €0.95 03/27/2025 03/28/2025 0%
2024 €0.95 0%
03/20/2024 €0.95 03/21/2024 03/22/2024 0%
2023 €0.95 0%
03/22/2023 €0.95 03/23/2023 03/24/2023 0%
2022 €0.95 0%
03/24/2022 €0.95 03/25/2022 03/28/2022 0%
2021 €0.95 0%
03/25/2021 €0.95 03/26/2021 03/29/2021 0%
2020 €0.95
06/25/2020 €0.95 06/26/2020 06/29/2020
*Amounts are shown in the stock exchange currency (EUR) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.